OPDIVO 10 mg/mL

OPDIVO 10 mg/mL is an intravenous injection containing nivolumab, used for various medical conditions. This single-dose vial is manufactured by E.R. Squibb & Sons, L.L.C. in the USA.

OPDIVO 10 mg/mL is primarily used in cancer treatments, including melanoma, lung cancer, and renal cell carcinoma. Nivolumab works by helping the immune system fight cancer cells. It is often used in combination with other therapies for better results.

Common effects of OPDIVO 10 mg/mL may include fatigue, nausea, and skin reactions. Some patients may experience more severe side effects, which should be discussed with a healthcare provider.

OPDIVO 10 mg/mL should be handled with care, following proper medical guidelines. It is important to store and administer this medication under the supervision of a healthcare professional to ensure safety and effectiveness.

OPDIVO 10 mg/mL may interact with other medications, including immunosuppressants and certain cancer treatments. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.